Department of General, Visceral and Vascular Surgery, University of Jena, Erlanger Allee 101, 07747 Jena, Germany.
Int J Colorectal Dis. 2013 Apr;28(4):537-45. doi: 10.1007/s00384-012-1553-0. Epub 2012 Aug 11.
Resection of colorectal liver or lung metastases is an established therapeutical concept at present. However, an affection of both these organs is frequently still regarded as incurable.
All cancer patients are documented in our prospective cancer registry since 1995. Data of patients who underwent liver and lung resection for colorectal metastases were extracted and analysed.
Sixty-five patients underwent surgery for liver and lung metastases. In 33 cases, the first distant metastasis was diagnosed synchronously to the primary tumour. For the remaining patients, median time interval between primary tumour and first distant metastasis was 18 months (5-69 months). Complete resection was achieved in 51 patients (79 %) and was less likely in patients with synchronous disease (p = 0.017). Negative margins (p = 0.002), the absence of pulmonary involvement in synchronous metastases (p = 0.0003) and single metastases in both organs (p = 0.036) were associated with a better prognosis. Five- and 10-year survival rates for all patients are 57 and 15 % from diagnosis of the primary tumour, 37 and 14 % from resection of the first metastasis and 20 and 15 % from resection of the second metastasis. After complete resection, 5- and 10-year survival rates increased to 61 and 18 %, 43 and 17 % as well as 25 and 19 %, respectively. Long-term survivors (≥10 years) were seen only after complete resection of both metastases.
Patients with resectable liver and lung metastases of the colorectal primary should be considered for surgery after multidisciplinary evaluation regardless of the number or size of the metastases or the disease-free intervals. Clear resection margins are the strongest prognostic parameter.
目前,结直肠肝或肺转移灶的切除术是一种既定的治疗方法。然而,这两个器官同时受到影响通常仍被认为是无法治愈的。
自 1995 年以来,我们的前瞻性癌症登记处记录了所有癌症患者的数据。提取并分析了接受结直肠转移灶肝肺切除术的患者数据。
65 例患者接受了肝肺转移灶手术。在 33 例患者中,首次远处转移与原发性肿瘤同时诊断。对于其余患者,原发性肿瘤与首次远处转移之间的中位时间间隔为 18 个月(5-69 个月)。51 例患者(79%)实现了完全切除,而同步疾病患者(p=0.017)更不可能实现完全切除。阴性切缘(p=0.002)、同步转移中无肺部受累(p=0.0003)和两个器官中均单发转移(p=0.036)与更好的预后相关。所有患者的 5 年和 10 年生存率分别为原发性肿瘤诊断后的 57%和 15%、首次转移灶切除后的 37%和 14%以及第二次转移灶切除后的 20%和 15%。完全切除后,5 年和 10 年生存率分别增加至 61%和 18%、43%和 17%以及 25%和 19%。只有在完全切除两个转移灶后,才会出现长期存活(≥10 年)的患者。
对于结直肠原发灶可切除的肝肺转移患者,应在多学科评估后考虑手术,无论转移灶的数量、大小或无疾病间隔如何。明确的切除边缘是最强的预后参数。